HSCs also promoted tumor angiogenesis by producing factors such as VEGF and angiopoietin [105–108] and have been shown to inhibit T cell proliferation and induce T cell apoptosis [109, 110], which suggests they may suppress the antitumor immune response in the liver. Here, VEGFA is linked to neoplasm.